基于循证医学看我国新型冠状病毒肺炎治疗方案的变迁

The vicissitudes of treatment protocol for COVID-19 in China based on the system of evidence-based Medicine

自2019年12月以来,中国湖北省武汉市陆续出现了多例新型冠状病毒肺炎病例,疫情后蔓延至国内的其他地区乃至境外。目前涉及全球200多个国家,构成全球大流行。针对暴发的疫情,我国相继发布了多个版本的诊疗方案。本文旨在从循证医学角度出发,关注我国新型冠状病毒肺炎治疗方案的变迁,并分析其推荐药物。

Since December 2019 COVID-19 appeared in Wuhan,Hubei Province,China,has spread to all provinces of China and even abroad.At present,it involves more than 200 countries around the world and forming a global pandemic.China has released several versions of diagnosis and treatment protocol for COVID-19.The purpose of this paper is to analyze and evaluate the recommended drugs of these protocol for COVID-19 in China based on the system of evidence-based medicine.